NEXTREAT is a preclinical CRO, which performs studies required for the safety-assessment and registration of pharmaceuticals, for the marketing-authorisation of chemicals, agrochemicals and other substances, as well as medical devices. Using state-of-the-art equipment, the experienced study directors and technical staff ensures that the projects are optimally performed, according to the sponsors’ requirements and the relevant guidelines.